FTLF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FTLF is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some positives, especially strong revenue growth and improving EPS in the latest quarter, but the current trend is still technically weak, analyst targets have been cut recently, and no major bullish trading signal is present. For an impatient investor unwilling to wait for a better entry, I would not buy here; I would hold and wait for clearer price strength.
FTLF is trading pre-market at 9.25, below the pivot level of 9.359 and under resistance at 9.787. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which points to a weak medium-term trend. MACD histogram is positive and expanding at 0.156, showing short-term momentum improvement, but RSI_6 at 36.82 is still neutral and does not confirm a strong reversal. Overall, the technical picture is mixed-to-bearish, with near-term bounce potential but no confirmed uptrend yet.
Latest quarter revenue rose 72.58% year over year in 2025/Q4, showing strong top-line expansion. EPS also increased sharply year over year, and analysts still maintain Buy ratings despite cutting price targets. Lake Street said recent weakness could be an attractive buying opportunity, and some core products are still showing good growth.
Net income fell 20.77% year over year in 2025/Q4, and gross margin declined to 33.53%, down 18.66% year over year, indicating profitability pressure. Analysts cut price targets recently, citing below-estimate Q4 results, slower online product sales, high protein costs, and the discontinuation of CBD. No news in the recent week, no recent congress trading data, and insider/hedge fund activity is neutral.
In 2025/Q4, FitLife Brands posted revenue of 25.91 million, up 72.58% year over year, which is a very strong growth signal. However, net income dropped to 1.64 million, down 20.77% year over year, and gross margin slipped to 33.53%, showing that earnings quality and profitability are under pressure even as sales expand. EPS increased to 0.16, up 300% year over year, but the margin compression suggests the growth has not fully translated into stronger overall profitability.
Recent analyst sentiment remains positive but less enthusiastic than before. On 2026-04-06, Roth Capital cut its target to 17 from 25 while keeping a Buy rating after Q4 earnings missed estimates and margins weakened. On 2026-04-02, Lake Street cut its target to 18 from 21 but also kept a Buy rating, saying near-term demand pressure appears temporary and weakness could be a buying opportunity. Overall, Wall Street is still constructive, but the direction of target revisions is negative, which lowers confidence in an immediate buy.
